4
Clinical Trials associated with BPR-101 / Not yet recruitingPhase 2 A Phase IIb Clinical Trial to Evaluate the Efficacy and Safety of BPR-101 Capsules in Combination With Metronidazole for the Prevention of Recurrence of Bacterial Vaginosis (BV).
This trial employed a multicenter, randomized, double-blind, parallel, placebo-controlled design to evaluate the preventive effect of BPR-101 capsules combined with metronidazole on the recurrence of BV, as well as the cure rate and safety.
一项评估BPR-101胶囊在细菌性阴道病(BV)患者中有效性及安全性的II期临床试验
[Translation] A Phase II clinical trial evaluating the efficacy and safety of BPR-101 capsules in patients with bacterial vaginosis (BV)
主要目的
评估BPR-101胶囊在BV患者中的有效性。
次要目的
评估BPR-101胶囊在BV患者中的安全性。
[Translation] Primary objective
To evaluate the efficacy of BPR-101 capsules in BV patients.
Secondary objective
To evaluate the safety of BPR-101 capsules in BV patients.
一项评估BPR-101胶囊多次给药在细菌性阴道病(BV)患者中的安全性、耐受性及初步有效性的Ib期临床试验
[Translation] A Phase Ib clinical trial evaluating the safety, tolerability and preliminary efficacy of multiple doses of BPR-101 capsules in patients with bacterial vaginosis (BV)
主要目的
评估BPR-101胶囊多次给药在BV患者中的安全性和耐受性。
次要目的
评估BPR-101胶囊多次给药在BV患者中的有效性。
[Translation] Primary objective
To evaluate the safety and tolerability of multiple administrations of BPR-101 capsules in BV patients.
Secondary objective
To evaluate the efficacy of multiple administrations of BPR-101 capsules in BV patients.
100 Clinical Results associated with BPR-101
100 Translational Medicine associated with BPR-101
100 Patents (Medical) associated with BPR-101
100 Deals associated with BPR-101